EMA — authorised 25 April 2022
- Marketing authorisation holder: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
- Status: approved
🇪🇺 Korsuva in European Union
EMA authorised Korsuva on 25 April 2022
Marketing authorisation
Korsuva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Korsuva approved in European Union?
Yes. EMA authorised it on 25 April 2022.
Who is the marketing authorisation holder for Korsuva in European Union?
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE holds the EU marketing authorisation.